Physician profile
Mark A Runnels
NPI 1144532391
$9,577.21
in general payments reported to CMS, 2019-2025
44 companies · $1,687 in 2025
The $1,687 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,756 · 2020: $536 · 2021: $1,051 · 2022: $860 · 2023: $1,180 · 2024: $2,506 · 2025: $1,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,138 · Travel and Lodging: $965 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,137.78 |
| Travel and Lodging | $965.19 |
| Education | $270.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,004.59 | 2019-2025 | Erleada, Akeega, Carvykti |
| Intuitive Surgical, INC. | $1,185.00 | 2019-2024 | |
| Astellas Pharma US INC | $1,114.23 | 2019-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $730.24 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $641.67 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $527.26 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $442.28 | 2019-2025 | |
| Abbvie INC. | $420.84 | 2019-2025 | Botox, Lupron Depot |
| Myriad Genetic Laboratories, INC. | $357.24 | 2022-2025 | Prolaris |
| Allergan, INC. | $270.12 | 2019-2021 | |
| C. R. Bard, INC. & Subsidiaries | $165.03 | 2020-2025 | Bard Urinary Drainage Bag |
| Coloplast Corp | $143.62 | 2019-2024 | |
| Amgen INC. | $139.37 | 2019-2024 | Prolia |
| Teleflex LLC | $130.56 | 2022-2023 | Urolift |
| Accord Healthcare, INC. | $119.82 | 2023-2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $113.85 | 2021-2025 | Keytruda, Lynparza |
| Verity Pharmaceuticals INC. | $109.35 | 2023-2025 | Trelstar |
| Boston Scientific Corporation | $89.70 | 2019-2023 | Spaceoar Vue System - 10ml |
| Progenics Pharmaceuticals, INC. | $79.22 | 2023-2025 | Pylarify |
| Olympus America INC. | $76.70 | 2020-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $66.55 | 2024-2025 | Adstiladrin |
| Tolmar, INC. | $63.40 | 2023-2025 | Jatenzo, Eligard |
| Novartis Pharmaceuticals Corporation | $59.38 | 2025 | |
| Procept Biorobotics Corporation | $54.26 | 2022-2025 | Aquabeam Robotic System |
| 180 Medical, INC. | $47.64 | 2025 | Gentlecath, Gentlecath Glide |
| Profound Medical Corp. | $42.98 | 2025 | Tulsa-Pro |
| Steris Corporation | $40.87 | 2024 | |
| Urogen Pharma, INC. | $31.08 | 2022-2024 | |
| Blue Earth Diagnostics | $29.53 | 2019-2025 | Posluma |
| Tolmar Pharmaceuticals, INC. | $29.27 | 2021 | |
| Acerus Pharmaceuticals Corporation | $26.30 | 2021 | |
| Inspire Medical Systems, INC. | $25.52 | 2024 | Inspire |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Ethicon US, LLC | $22.28 | 2019 | |
| Axonics, INC. | $20.29 | 2022 | |
| Civco Medical Instruments | $18.46 | 2025 | |
| Coopersurgical, INC. | $17.56 | 2025 | Onetrac Lx |
| Medtronic, INC. | $16.58 | 2025 | Interstim |
| Mission Pharmacal Company | $15.72 | 2022 | |
| Rochester Medical Corporation | $15.42 | 2019 | |
| Photocure INC | $14.12 | 2021 | |
| Angiodynamics, INC. | $13.81 | 2024 | Nanoknife |
| Endo Pharmaceuticals INC. | $13.03 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Runnels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.